For ophthalmic use only. Instill one drop into the conjunctival sac of the affected eye(s). Avoid touching the dropper tip to the eye or any other surface to prevent contamination.

Ketorolac acts by inhibiting prostaglandin synthesis through non-selective inhibition of cyclooxygenase (COX-1 and COX-2) enzymes. Prostaglandins are mediators of inflammation and pain, so inhibiting their synthesis reduces these symptoms in the eye.

• •Hypersensitivity to Ketorolac Tromethamine or any component of the formulation.
• •Patients with known hypersensitivity to other NSAIDs (e.g., aspirin, ibuprofen) may have cross-sensitivity.

Store below 30°C. Protect from light. Do not freeze.

Overdose is unlikely with topical ophthalmic administration. If accidental ingestion occurs, seek medical advice. If excessive drops are applied to the eye, flush with lukewarm water.

Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised when used by breastfeeding mothers as NSAIDs can be excreted in human milk.